FDA clears Bacchus' thrombectomy catheter:
This article was originally published in Clinica
Executive Summary
Bacchus Vascular (Santa Clara, California) has received US FDA 510(k) marketing clearance for its minimally invasive Solera thrombectomy catheter for removing blood clots in patients with haemodialysis access grafts. The product, which was also recently cleared for sale in Europe, is a battery-operated, handheld device that macerates blood clots in a rapid and effective manner.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.